Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Merck to Pay $688 Million to Settle Investor Lawsuits

In a press release issued today, Merck (NYSE: MRK  ) announced it has reached an agreement in principle with plaintiffs in two class action lawsuits brought by investors, both related to the release of results from Merck's ENHANCE study in 2008.

The legal actions were brought by shareholders who had purchased either Merck or Schering-Plough stock between December 2006 and March 2008. The two companies merged in 2009.

The lawsuits allege that investors lost money when Merck announced unfavorable results of its much-anticipated ENHANCE study. In a statement, Merck said it "continues to believe that both companies acted responsibly in connection with the ENHANCE study, and this agreement contains no admission of liability or wrongdoing."

The agreement -- which needs court approval -- would resolve the two federal securities class action lawsuits currently pending in the U.S. District Court for the District of New Jersey. Under the arrangement, Merck will pay $215 million to resolve the lawsuit brought against Merck defendants and $473 million to bring an end to proceedings against Schering-Plough defendants.

Merck had previously taken a one-time, $493 million charge related to the legal actions. As a result, Merck does not expect the settlement to impact 2013 operations results. However, the charge reduced the company's previously reported fourth-quarter 2012 GAAP EPS results from $0.46 to $0.30 per share, according to the company.

Merck executive vice president and general counsel Bruce Kuhlik was quoted in the company press release as saying, "This agreement avoids the uncertainties of a jury trial and will resolve all of the remaining litigation in connection with the ENHANCE study."


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2256749, ~/Articles/ArticleHandler.aspx, 9/29/2016 11:16:01 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,308.84 -30.40 -0.17%
S&P 500 2,167.61 -3.76 -0.17%
NASD 5,297.40 -21.15 -0.40%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/29/2016 11:00 AM
MRK $62.16 Down -1.14 -1.80%
Merck and Co. CAPS Rating: ****